What the COPD management calculator organizes
Chronic obstructive pulmonary disease, or COPD, is a chronic lung condition in which long-term injury to the airways and air sacs limits airflow, especially while breathing out.
Tobacco smoke is a major cause, but occupational dust or fumes, indoor and outdoor pollution, repeated infection, impaired lung development, and genetic factors can also contribute.
Cough and phlegm may be dismissed as smoking or a lingering cold, while slowly increasing breathlessness may be attributed to age, so diagnosis is often delayed.
This calculator separates four questions that are often mixed together: whether spirometry should be discussed, whether an entered spirometry result supports persistent airflow obstruction, how symptoms and the previous year of exacerbations map to the GOLD 2026 A-B-E framework, and which self-management actions are missing.
It also calculates smoking exposure in pack-years and turns inhaler use, an action plan, exercise or pulmonary rehabilitation, vaccination review, and follow-up into a transparent checklist.
Checklist completion is not a severity, survival, or prognosis score.
Emergency symptoms come before calculation
Severe breathlessness at rest or inability to speak a full sentence, blue lips, new confusion or marked drowsiness, chest pain, or fainting needs emergency assessment now.
A COPD-like flare can overlap with pneumonia, pneumothorax, pulmonary embolism, heart attack, or heart failure, so do not wait for a calculator result.
Five case-finding signals and pack-years
GOLD patient material uses five simple signals: cough on most days, phlegm on most days, becoming breathless more easily than people of the same age, age 40 or older, and current or former smoking.
Three or more signals should prompt a conversation with a clinician about COPD and spirometry.
The threshold starts a conversation; it does not diagnose COPD or confirm the condition, and a score below three does not exclude disease.
A never-smoker may still need assessment when symptoms and non-tobacco exposures are present.
Five-signal formula
Add one point for each of the three usual symptoms, age at least 40, and any current or former smoking history.
A total of 3 out of 5 or more turns on the discuss-spirometry signal.
Pack-year formula
Pack-years = cigarettes per day ÷ 20 × years smoked.
Twenty cigarettes a day for 30 years equals 30 pack-years; ten a day for 20 years equals 10 pack-years.
Pack-years alone do not diagnose COPD or determine lung-cancer screening eligibility.
Why post-bronchodilator spirometry matters
Spirometry is essential to confirm COPD in the appropriate clinical setting.
FEV₁ is the volume forced out in the first second after a full breath, while FVC is the full forced vital capacity exhaled during the maneuver.
The GOLD 2026 fixed-ratio criterion is post-bronchodilator FEV1/FVC < 0.70.
Symptoms, exposure history, test quality, age, and alternative diagnoses still require clinical interpretation; the ratio is not a stand-alone self-diagnosis.
GOLD 2026 grades of airflow obstruction after COPD is confirmed| Grade | FEV₁ percent predicted | Airflow description |
|---|
| GOLD 1 | ≥ 80% | Mild airflow obstruction |
| GOLD 2 | 50% to 79% | Moderate airflow obstruction |
| GOLD 3 | 30% to 49% | Severe airflow obstruction |
| GOLD 4 | < 30% | Very severe airflow obstruction |
GOLD 1-4 and A-B-E are different axes
GOLD 1 through 4 describe the degree of airflow obstruction from FEV₁ after COPD is confirmed.
A, B, and E organize symptom burden and exacerbations in the previous year for a treatment discussion.
A person may have a relatively preserved FEV₁ but still be in Group E after an exacerbation, or a low FEV₁ but Group A or B when no recent exacerbation occurred.
mMRC, CAAT, and the GOLD 2026 A-B-E framework
The modified Medical Research Council, or mMRC, scale grades how breathlessness limits walking and daily activity from 0 to 4.
Grade 0 means breathlessness only with strenuous exercise, grade 2 means walking slower than peers or stopping for breath on level ground, and grade 4 means breathlessness prevents leaving home or affects dressing.
GOLD uses mMRC ≥ 2 as the higher-symptom threshold.
The Chronic Airways Assessment Test, or CAAT, measures a broader effect of airway symptoms on daily life; CAAT ≥ 10 is the corresponding threshold.
This page accepts only a total score already obtained from an authorized CAAT tool and does not reproduce the copyrighted questionnaire items.
GOLD 2026 A B E reference groups by exacerbation history and symptom burden| Group | Previous-year exacerbations | Symptom axis | Planning focus |
|---|
| A | 0 moderate or severe | mMRC 0-1 and CAAT < 10 | Lower entered symptoms without an event |
| B | 0 moderate or severe | mMRC ≥ 2 or CAAT ≥ 10 | Symptom relief and activity limitation |
| E | ≥ 1 moderate or severe | Independent of symptom score | Preventing another exacerbation |
The important 2026 change
The 2025 framework generally placed patients in Group E after at least two moderate exacerbations or one hospitalization.
GOLD 2026 broadened Group E to one or more moderate or severe exacerbations in the previous year because even one moderate event predicts future risk.
A single event treated with antibiotics or systemic steroids without hospital admission can therefore produce Group E in this calculator.
How to use the calculator step by step
- Start with diagnosis status and the five signals.
Enter usual cough, sputum, breathlessness compared with peers, age, smoking status, and past average smoking exposure.
- Copy spirometry values exactly.
Keep post-bronchodilator FEV₁/FVC separate from FEV₁ percent predicted, and leave unknown values blank.
- Enter symptoms and count events once.
Select mMRC, optionally add a known CAAT score, and separate non-admitted moderate events from emergency-department or hospital events.
- Check current deterioration separately.
Current worsening, resting oxygen, and emergency signs require a different response from a historical event count.
- Use the result as a visit-preparation list.
Bring dates of exacerbations, inhaler use, missing action-plan items, and the actual inhaler to the next visit rather than reporting only one group letter.
Worked examples
Example 1: higher symptoms without an exacerbation
A 65-year-old former smoker who averaged 20 cigarettes a day for 30 years has 30 pack-years.
Post-bronchodilator FEV₁/FVC of 58% supports the fixed-ratio obstruction signal, and FEV₁ of 62% predicted maps to GOLD 2.
mMRC 2 or CAAT 14 with no moderate or severe event in the previous year maps to Group B.
The useful next step is not merely recording B; it is reviewing inhaler technique, other causes of breathlessness, and an exercise or pulmonary rehabilitation plan.
Example 2: one non-admitted moderate exacerbation
Even with mMRC 1 and CAAT 8, one event requiring antibiotics and systemic steroids in the previous year maps to Group E under GOLD 2026.
Do not omit the event because it did not lead to admission.
The visit should review adherence, technique, exposure triggers, vaccination, a written action plan, and whether maintenance treatment remains appropriate.
This calculator does not choose medication; blood eosinophils, coexisting asthma, prior response, adverse effects, and device suitability require clinical judgment.
Turning checklist gaps into practical actions
Smoking cessation and exposure reduction
Smoking cessation is one of the most important disease-modifying actions in COPD.
Combining counseling, social support, and approved cessation treatment is generally more effective than relying on willpower alone.
Occupational dust and fumes, indoor smoke, and severe outdoor pollution should also be addressed.
Inhaler adherence and technique
Metered-dose, dry-powder, and soft-mist devices require different preparation and inhalation speeds.
Bring the actual device to follow-up and demonstrate every step rather than relying on a one-time explanation.
Missed doses may reflect cost, hand strength, inspiratory flow, complexity, memory, or side effects, so identify the cause instead of stopping treatment independently.
Pulmonary rehabilitation and activity
Pulmonary rehabilitation combines individualized aerobic and strength training with education and self-management support.
Avoiding all activity because of breathlessness can worsen deconditioning and make the same task feel harder, so ask for a safe starting plan matched to current capacity.
Vaccination review and a written action plan
GOLD and Korean national health information emphasize vaccination review for infections that can precipitate COPD exacerbations.
Exact influenza, COVID-19, pneumococcal, RSV, and other schedules depend on country, age, products, prior doses, and immune status, so the calculator records review rather than prescribing a schedule.
A written plan should define usual symptoms, warning changes, contact details, and care thresholds; it is not permission to self-prescribe antibiotics or steroids.
Oxygen saturation and current worsening
The Korean Disease Control and Prevention Agency notes that stable resting oxygen saturation of 88% or lower can support assessment for home oxygen therapy, with additional clinical criteria in some patients.
A fingertip oximeter can be affected by cold hands, motion, nail products, circulation, and device quality, while some people have individualized prescribed targets.
This calculator therefore treats 88% as a prompt-assessment signal and never as an automatic oxygen prescription.
Worsening breathlessness, cough, sputum volume, or sputum color should still prompt clinical contact even when the displayed saturation looks similar to usual.
Do not change medication from a group letter
A-B-E is a clinical discussion framework, not an automatic prescription engine.
Bronchodilators, inhaled corticosteroids, systemic steroids, antibiotics, and oxygen depend on prior treatment, blood eosinophils, coexisting asthma, infection, adverse effects, device ability, and other conditions.
Do not start, stop, increase, or switch treatment from this result alone.
Frequently asked questions
Does FEV₁/FVC at or above 70% rule out COPD?
It does not meet the GOLD fixed-ratio criterion, but a clinician may review test quality, a borderline result, age, symptoms, timing, and alternative interpretation.
The calculator flags a conflict when a confirmed diagnosis and a ratio at or above 70% are entered together.
Can I complete the CAAT questionnaire here?
No.
This page does not reproduce CAAT items.
Enter a total score only when it was obtained from an authorized tool.
If the score is unknown, the symptom axis can use mMRC alone.
How do I separate moderate and severe exacerbations?
For this tool, enter an event treated with antibiotics, systemic steroids, or an unscheduled visit without admission as moderate.
Enter an emergency-department or hospital event as severe, and do not count the same event twice.
Does 100% checklist completion mean COPD is controlled?
No.
Completion describes selected management preparations only.
It does not measure lung function, comorbidities, current stability, future risk, or survival.
Emergency signs always override the completion percentage.
Can a never-smoker use the calculator?
Yes.
Occupational exposures, indoor or outdoor pollution, prior infection, impaired lung development, and genetic factors can contribute to COPD.
Pack-years will be zero, but symptoms and valid spirometry still matter.
Does Group E mean I should immediately use a particular inhaler?
No.
Group E prioritizes exacerbation prevention for clinical review.
Medication choice depends on existing therapy, eosinophils, asthma, technique, adverse effects, and individual circumstances.
Rule date, Korea context, and primary sources
The calculation uses the GOLD 2026 Report v1.3 and Pocket Guide v1.1 as verified on July 19, 2026.
Korean explanations of spirometry, smoking cessation, inhaler education, pulmonary rehabilitation, vaccination review, exacerbations, and oxygen assessment were cross-checked against the Korea Disease Control and Prevention Agency health portal, updated June 1, 2026.
A direct Korean National Law Information Center OPEN API search found no statute title matching COPD, and this tool includes no legal benefit rate, insurance payment, or hospital-cost formula.
The medical framework is globally relevant, but vaccination schedules, emergency numbers, coverage, and referral pathways must follow the user’s country and care team.
Take the full summary to your next visit
Record the spirometry values, mMRC or CAAT result, dates and treatment of every previous-year exacerbation, missed inhaler doses, and each incomplete management action instead of bringing only one A-B-E letter.
Bring the actual inhaler to demonstrate technique and use the list to agree on a written action plan, exercise or pulmonary rehabilitation, vaccination review, and the next spirometry date.
Do not wait for a scheduled appointment if symptoms acutely worsen or emergency signs appear.